Justifying its ban on the medicine, the US FDA said it “reviewed several incidents of serious adverse events associated with ...
Analysts at Wedbush upped their Q2 2025 earnings per share estimates for argenx in a report released on Friday, December 27th. Wedbush analyst D. Nierengarten now anticipates that the company will ...
Vaccines are a big deal. A landmark study published in The Lancet this spring calculated global vaccination efforts targeting ...
Iptacopan hydrochloride is under clinical development by Novartis and currently in Phase II for Microscopic Polyangiitis (MPA).
Christine Porter worried about what each passing hour could bring as her mother battled a life-threatening illness in the ICU at University of Vermont Health Network – Champlain Valley Physicians ...
Bioven by Biopharma Plasma for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval
Bioven is under clinical development by Biopharma Plasma and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback